Pancreatic Cancer Research

ResearcherHospital Italiano de Buenos AiresActive in the last 2 years

Oscar Mazza

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6638-8659; OpenAlex author ID A5040852361, A5125721553. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
22
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 3 papers · 2024: none · 2025: none · 2026: 2 papers

Papers 9

  1. Stage-resolved gene drivers of pancreatic ductal adenocarcinoma progression and therapeutic vulnerabilities. Co-author DOI 10.1016/j.isci.2026.115164↗
  2. Pathway-driven therapeutic stratification in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.tranon.2026.102920↗
  3. Prognostic Factors in Resected Pancreatic Ductal Adenocarcinoma: Is Neutrophil-Lymphocyte Ratio a Useful Marker? Co-author DOI 10.1007/s12029-022-00839-7↗
  4. Technical Implications for Surgical Resection in Locally Advanced Pancreatic Cancer. Last author DOI 10.3390/cancers15051509↗
  5. [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. Co-author PMID 37582144↗
  6. [Long-term survival after pancreatic cancer surgery]. Last author PMID 34633955↗
  7. [New progress in the treatment of locally advance pancreatic cancer]. Last author PMID 31864229↗
  8. Use of radiotherapy in patients with palliative double bypass for locally advanced pancreatic adenocarcinoma. Co-author DOI 10.3857/roj.2018.00206↗
  9. Groove pancreatitis vs groove pancreatic adenocarcinoma. Report of two cases and review of the literature. Last author PMID 24303693↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Martín de Santibañes · 6 shared papers, 2013–2023 · strength 0.82
  2. Eduardo de Santibáñes · 5 shared papers, 2018–2023 · strength 0.78
  3. María Eugenia Pasqualini · 3 shared papers, 2023–2026 · strength 0.57
  4. María Noé Garcia · 3 shared papers, 2023–2026 · strength 0.57
  5. Agustín Yaneff · 3 shared papers, 2023–2026 · strength 0.57
  6. Nicolas Alejandro Fraunhoffer · 3 shared papers, 2023–2026 · strength 0.57
  7. Eduardo Chuluyán · 3 shared papers, 2023–2026 · strength 0.57
  8. Juan Iovanna · 3 shared papers, 2023–2026 · strength 0.57
  9. Daniela Laura Papademetrio · 3 shared papers, 2023–2026 · strength 0.57
  10. Nelson Dusetti · 3 shared papers, 2023–2026 · strength 0.57
  11. Daniel Grasso · 3 shared papers, 2023–2026 · strength 0.57
  12. Jonathan Garnier · 2 shared papers, 2026 · strength 0.42
  13. Brice Chanez · 2 shared papers, 2026 · strength 0.42
  14. Ana Sahores · 2 shared papers, 2023–2026 · strength 0.35
  15. Ignacio Guillermo Merlo · 2 shared papers, 2021–2023 · strength 0.33
  16. Analía Meilerman Abuelafia · 1 shared paper, 2026 · strength 0.21
  17. Pascal R. Hammel · 1 shared paper, 2026 · strength 0.21
  18. Betina González · 1 shared paper, 2023 · strength 0.14
  19. Carlos Alberto Davio · 1 shared paper, 2023 · strength 0.14
  20. Patricia Santofimia‐Castaño · 1 shared paper, 2023 · strength 0.14
  21. Juan Glinka · 1 shared paper, 2018 · strength 0.08
  22. Jeremías Goransky · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.